2015 MDEA Finalists: Oraya iRay Radiotherapy System

The Oraya iRay Radiotherapy System, manufactured by Oraya Therapeutics Inc. (United States), is the first device using X-rays to treat wet age-related macular degeneration (AMD) by precise dose and targeting to the retina’s diseased area. Treatments can reduce need for frequent eye injections. AMD is a leading cause of elder vision loss.

Supply/design credits: Bridge Design, Design Science